CLINICAL TRIALS PROFILE FOR ROBINUL FORTE
✉ Email this page to a colleague
All Clinical Trials for ROBINUL FORTE
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00579085 ↗ | Double Blind Placebo Controlled Study of Outpatient Intravenous Ketamine for the Treatment of CRPS | Completed | Drexel University College of Medicine | Phase 2 | 2006-09-01 | Complex Regional Pain Syndrome is a debilitating and extremely difficult to treat condition. There is a large body of evidence demonstrating the therapeutic value of N-methyl-D-aspartate (NMDA)-receptor antagonists in CRPS. The NMDA antagonist ketamine has been shown to be effective in the treatment of CRPS, resulting in complete remission of the disease in some patients. The purpose of this study is to evaluate intravenous outpatient infusion of sub-anesthetic doses of ketamine for the treatment of CRPS. A thorough evaluation of this procedure, providing information into the degree of relief and which of the constellation of RSD symptoms are best alleviated by this procedure would result in the optimization of this therapy for the treatment of CRPS. |
| NCT01191398 ↗ | Effectiveness of Atropine and Glycopyrrolate to Reduce Hyper Salivation With Ketamine Sedation | Completed | Craig J. Huang | N/A | 2010-06-01 | The purpose of this study is to determine if the antisialagogues (anti-salivary agents), Atropine and Glycopyrrolate, are effective in reducing hypersalivation when sedating patients with Ketamine for procedural sedation in the emergency department or abscess clinic. The investigators will measure salivary flow rate by collecting oral secretions by oral suctioning over a 30 minute time period starting with the administration of Ketamine. The investigators hypothesize that patients who receive either atropine or glycopyrrolate will have fewer oral secretions than patients who receive placebo. |
| NCT02872935 ↗ | Minimizing Nausea and Vomiting During Spinals for CS | Terminated | Kokila N Thenuwara | Phase 4 | 2015-05-15 | In parturients undergoing Cesarean section under spinal anesthesia, co-loading of 1 liter of crystalloids, with placing the spinal, along with administering a phenylephrine infusion and glycopyrrolate, enables placing a spinal with minimal perioperative nausea and vomiting and good intra and post-operative pain relief. |
| NCT02872935 ↗ | Minimizing Nausea and Vomiting During Spinals for CS | Terminated | University of Iowa | Phase 4 | 2015-05-15 | In parturients undergoing Cesarean section under spinal anesthesia, co-loading of 1 liter of crystalloids, with placing the spinal, along with administering a phenylephrine infusion and glycopyrrolate, enables placing a spinal with minimal perioperative nausea and vomiting and good intra and post-operative pain relief. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for ROBINUL FORTE
Condition Name
Clinical Trial Locations for ROBINUL FORTE
Trials by Country
Clinical Trial Progress for ROBINUL FORTE
Clinical Trial Phase
Clinical Trial Sponsors for ROBINUL FORTE
Sponsor Name
